Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial ...

Global warming is increasingly evident. 2025 was the third-hottest year on record, both globally and in Europe. The past three years — 2024, 2023 and 2025, in that order — were the hottest ever ...

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, ...

Eni and Q8 Italy have approved a major joint investment to build a new 500,000-tonne-per-year biorefinery in Priolo, Sicily, using Eni’s Ecofining™ technology to produce HVO and Sustainable Aviation ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand research, development and manufacturing capabilities, supporting its long-term growth strategy and global pipeline in ...